Gilead Sciences (GILD)
$72.52
0.04 (0.06%)
GILD Stock Quote Delayed 30 Minutes
If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names
Evaluating and making money from biotech stocks is incredibly difficult. These three ideas should help your quest if buying in July.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
90.93B
PE Ratio
207.20
EPS
0.35
Volume (Avg. Vol.)
1.44M
Day's Range
$72.02 - $73.32
52-Week Range
$62.07 - $87.86
Dividend & Yield
$3.00 (4.14%)
GILD Stock Predictions, Articles, and Gilead Sciences News
7 Cheap Biotech Stocks With Major Upside Potential
While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks.
7 Dividend Stocks to Buy Now: June 2024
These dividend stocks to buy now will reward investors with income now and growth as the market breadth expands.
Defying the Norms: 3 High P/E Stocks With Room to Run
Gilead Sciences, Crowdstrike and DataDog might be the best high P/E stocks to buy, offering substantial growth despite elevated valuations.
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
Biotech stocks operate under a core ethos. While there’s been much talk about financially viable sectors – from tech to cryptocurrencies to even precious metals…
GILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q1 2024
GILD stock results show that Gilead Sciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
3 Stocks at 52-Week Lows Poised for a Powerful Rebound
Starbucks, Gilead, and Vale are three stocks at 52-week lows that show signs of recovery potential and long-term growth prospects.
Why Is Xilio Therapeutics (XLO) Stock up 168% Today?
Xilio Therapeutics stock is heading higher on Thursday with heavy trading of XLO shares after announcing a deal with Gilead.
7 Value Stocks to Buy at a 52-Week Low in March
These seven value stocks to buy all trade at low valuations, and have the potential to make big recoveries.
